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Background: The study was conducted to determine the clinical and cost effectiveness of enhanced multi-
disciplinary teams (EMDTs) vs. ‘usual care’ for the treatment of pressure ulcers in long term care (LTC) facilities in
Ontario, Canada
Methods: We conducted a multi-method study: a pragmatic cluster randomized stepped-wedge trial, ethnographic
observation and in-depth interviews, and an economic evaluation. Long term care facilities (clusters) were randomly
allocated to start dates of the intervention. An advance practice nurse (APN) with expertise in skin and wound care
visited intervention facilities to educate staff on pressure ulcer prevention and treatment, supported by an off-site
hospital based expert multi-disciplinary wound care team via email, telephone, or video link as needed. The primary
outcome was rate of reduction in pressure ulcer surface area (cm2/day) measured on before and after standard
photographs by an assessor blinded to facility allocation. Secondary outcomes were time to healing, probability of
healing, pressure ulcer incidence, pressure ulcer prevalence, wound pain, hospitalization, emergency department
visits, utility, and cost.
Results: 12 of 15 eligible LTC facilities were randomly selected to participate and randomized to start date of the
intervention following the stepped wedge design. 137 residents with a total of 259 pressure ulcers (stage 2 or
greater) were recruited over the 17 month study period. No statistically significant differences were found between
control and intervention periods on any of the primary or secondary outcomes. The economic evaluation
demonstrated a mean reduction in direct care costs of $650 per resident compared to ‘usual care’. The qualitative
study suggested that onsite support by APN wound specialists was welcomed, and is responsible for reduced costs
through discontinuation of expensive non evidence based treatments. Insufficient allocation of nursing home staff
time to wound care may explain the lack of impact on healing.
Conclusion: Enhanced multi-disciplinary wound care teams were cost effective, with most benefit through cost
reduction initiated by APNs, but did not improve the treatment of pressure ulcers in nursing homes. Policy makers
should consider the potential yield of strengthening evidence based primary care within LTC facilities, through
outreach by APNs.
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A pressure ulcer (PU), also known as a pressure sore, de-
cubitus ulcer, or bedsore, is a localized injury to the skin
and/or underlying tissue caused by pressure and/or shear
[1]. Those at greatest risk for developing PUs are the eld-
erly, the critically ill, the neurologically impaired, and those
who suffer from conditions associated with immobility [2].
PUs are staged with a 4 point classification system denoting
severity, ranging from stage I (intact skin, non-blanchable
erythema), to stage IV (full thickness tissue loss exposing
bone, tendon, or muscle) [1]. In 2007 the National Pressure
Ulcer Advisory Panel added 2 categories of PUs: Deep Tis-
sue Injury (DTI) (intact discolored skin due to damage to
underlying soft tissue), and Unstageable (full-thickness tis-
sue loss, depth unknown due to slough or eschar on the
wound’s surface) [1].
Pressure ulcers (PUs) are problematic across healthcare
settings throughout the world [3,4]. Financial costs associ-
ated with PUs are high [5,6]. Pain [7], depression [8], altered
self-image [8], and increased morbidity and disability [9]
are consequences of this largely preventable condition.
The Medical Advisory Secretariat (MAS) [10], a unit
that prepares evidence-based analyses to support policy
relevant decision-making by the Ontario Ministry of
Health and Long-Term Care (MOHLTC), conducted a
review of the literature leading them to suggest that an
enhanced multi-disciplinary team (EMDT) to assess
wound variables and determine optimal treatment would
be effective for the treatment of PUs, but the compos-
ition of these teams, specific roles and responsibilities of
members, and intensity of involvement were far less cer-
tain [11]. Service delivery by expert teams traditionally
necessitates physical transport of patients to these teams,
or vice versa. Telemedicine offers a means to deliver
chronic wound care services remotely [12,13].
Due to the complexity of PUs, recommendations made
by the MAS expert panel, high PU prevalence rates in
Long Term Care (LTC) facilities in Canada [3], the pau-
city of high quality evidence related to pressure ulcer
treatment [14], and the potential to enhance care deliv-
ery using telemedicine we conducted the following study
to evaluate the clinical and cost effectiveness of an
EMDT supported by telemedicine vs. 'usual' care (UC)
for the treatment of PUs in LTC.
The study was funded by the MOHLTC, the Canadian
Patient Safety Institute, and the Central Community Care




We conducted a multi-method study: a pragmatic stepped-
wedge cluster- randomized trial, ethnographic observation
and in-depth interviews, and an economic evaluation. Astepped wedge design [15] was selected for the trial in order
to retain the power of randomization while offering all facil-
ities enrolled in the trial exposure to what was believed to
be a desirable intervention and to enable delivery of the
intervention to these facilities by a small study team.Population
The study population was residents with Stage II or greater
PUs residing in eligible LTC facilities situated within 2 geo-
graphic regions (Local Health Integration Networks-
LHINs) in southern Ontario, Canada.Eligibility was assessed at 3 levels: LTC facility, resident, and
wound
Facilities were eligible and approached for the study by the
principal investigator if they had a minimum of 100 beds,
were within 100 kilometers from the hospital housing the
expert wound team, had a PU prevalence greater than the
provincial average (5.5%, based on data collected from LTC
facilities in Ontario by the Canadian Institute of Health Re-
search in 2009), and the facility administrator provided con-
sent. The criteria of a minimum of 100 beds was applied in
order to maximize the reach of the study staff, while ensur-
ing that average sized facilities in Ontario (170 beds) were
represented in the study. The criteria of facilities being
within 100 km of the hospital housing the wound care team
was applied to allow for the physical transport of residents
to the wound care team if deemed necessary as determined
by the study referral rubric. The criteria of greater than pro-
vincial average PU prevalence rates was applied since these
are the facilities within which the intervention would be sit-
uated if the intervention was found to be effective.Residents
in consenting LTC facilities were eligible if they had a re-
ported PU (stage II or greater), and provided informed con-
sent. Their legal representative was approached for consent
if the resident was deemed incapable by the most respon-
sible clinician. Facility staff obtained verbal consent to re-
lease names of eligible residents to the research assistants.
Research assistants were responsible for participant recruit-
ment. Individuals were approached to participate after facil-
ities had been randomised.
If a patient had more than one wound, all were in-
cluded. Stage I and Deep Tissue Injury PUs were ex-
cluded as skin typically remains intact, and are therefore
not amenable to accurate measurement of wound sur-
face area.
Facility enrollment in the 17- month study occurred in
October 2010. Residents were recruited from participat-
ing facilities from October 2010-February 2012, with
data collection closing in March 2012.
The study was approved by the research ethics boards
of the University of Toronto and the hospital housing
the acute care wound team.
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Randomisation was at the level of the facility (cluster)
due to the educational component of the intervention
being delivered at the facility level. LTC facilities were
randomised to start date of the intervention by a re-
searcher external to the study team using a computer-
generated random number sequence, giving each LTC
facility different lengths of control and intervention pe-
riods (Table 1).Intervention: Enhanced Multi-Disciplinary Team (EMDT)
Every LTC facility in both groups appointed a wound
care lead (RN or RPN) at study start to serve as the pri-
mary contact for the study team. The control period
ranged from 3-12 months per facility as determined by
randomisation order (Table 1). Blinding of facility staff
or residents was not possible due to the nature of the
intervention.
The Enhanced Multi-Disciplinary Team (EMDT) con-
sisted of advanced practice nurses (APNs) who provided
outreach to LTC facilities, and were linked to a hospital
based expert wound care team. The APNs, funded by
the study budget, had expertise in skin and wound care
(two were certified enterostomal therapists with over
5 years of experience, one was a masters prepared nurse
with over 10 years of experience in wound care). They
visited LTC facilities to educate staff on the prevention
and treatment of pressure ulcers, consulting with a hos-
pital based expert wound care team via email, telephone,
or video link following a referral rubric (Figure 1). The
expert wound team was situated in a large teaching hos-
pital. It was led by a nurse practitioner and included a
chiropodist, an occupational therapist, and a plastic sur-
geon that had ready access to a wide variety of additionalTable 1 Study design
Time (Months) 1 2 3 4 5 6 7
Facility number 12 - - - - - - -
11 - - - - - - c
10 c c c c c c c
9 c c c c c c c
8 c c c c c c c
7 c c c c c c c
6 c c c c c c c
5 c c c c c c c
4 c c c c c c P1
3 c c c c c P1 P1
2 c c c c P1 P1 P1
1 c c c P1 P1 P1 P2
c = Control; P1 = Intervention- Phase 1 (onsite one day/week); P2 = Intervention Phahospital based specialists if consultations were deemed
necessary.
The intervention was implemented in 2 phases at each
LTC facility. Phase 1 was 3 months in length at each fa-
cility and focused on training of LTC staff. APNs spent
one day per week at each facility to establish multi-
disciplinary wound care teams within facilities, and to
educate direct care staff (personal support workers,
nursing assistants, registered nurses) about PU preven-
tion and treatment (case based teaching at the bedside,
and structured group sessions customized to meet facil-
ity’s needs). All recommendations were based on the
Registered Nurses’ Association of Ontario (RNAO) evi-
dence based guidelines (updated in 2007) [16] contextu-
alized to the LTC setting. In addition APNs worked
directly with a facility wound care lead, mentoring them
in the assessment of wounds enrolled in the study,
digital wound photography, and completion of standard-
ized assessment and treatment forms, liaising with the
expert team following a referral rubric developed for the
study to reflect real world practice (Figure 1).
Phase 2 (1-11 months in length) involved primarily re-
mote support of the facility wound care lead by the
APNs via email and telephone. The wound care lead was
to assess PUs, complete assessment and treatment
forms, take digital photos, and transmit de-identified
data via email to the APNs every 2 weeks. APNs
reviewed cases with the wound care lead via telephone
and email, reviewing referral criteria with them, and
consulting with the expert team accordingly. APNs
would visit the facility when necessary or if requested to
do so by the facility wound care lead. This process was
repeated every 2 weeks for all PUs until healed, or until
the end of the study period, whichever came first. Face
to face (or video-link) visits with the expert team8 9 10 11 12 13 14 15 16 17
c c c c c c P1 P1 P1 P2
c c c c P1 P1 P1 P2 P2 P2
c c c c c P1 P1 P1 P2 P2
c c c c P1 P1 P1 P2 P2 P2
c c c P1 P1 P1 P2 P2 P2 P2
c c P1 P1 P1 P2 P2 P2 P2 P2
c P1 P1 P1 P2 P2 P2 P2 P2 P2
P1 P1 P1 P2 P2 P2 P2 P2 P2 P2
P1 P1 P2 P2 P2 P2 P2 P2 P2 P2
P1 P2 P2 P2 P2 P2 P2 P2 P2 P2
P2 P2 P2 P2 P2 P2 P2 P2 P2 P2
P2 P2 P2 P2 P2 P2 P2 P2 P2 P2
se 2 (primarily remote bi-weekly).
Figure 1 Referral rubric.
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the referral rubric.
Control: "Usual" care
Wound care within LTC facilities was typically provided
by registered nurses (RNs), registered practical nurses
(RPNs), personal support workers (PSWs), and nutri-
tionists, who may or may not have had expertise in
wound care. Although facilities were to have wound care
teams in place within the facility as mandated by the
MOHLTC in 2010, only 3 of the 12 facilities had wound
care teams, with the composition and function of these
‘teams’ being highly variable. Access to other disciplines
(e.g. Enterostomal Therapists, Physiotherapists, Occupa-
tional Therapists) was available, typically on a reactive
basis. Wound care specialists who were requested by fa-
cilities to assess and treat advanced wounds, costs that
were covered by the MOHLTC upon facility application
for reimbursement, were typically employed by wound
product companies, or were in private practice and re-
imbursed on a fee-for-service basis.
Outcome measures
The primary outcome was rate of reduction in PU sur-
face area (cm2/day), judged by an external study staff
member blinded to facility allocation who was trained in
wound surface area measurement captured by digital
photography. Research assistants visited each facility
every two weeks to obtain digital photos of PUs. Meas-
urement of all photos was delayed until 2 months prior
to study completion to decrease risk of un-blinding the
assessor to facility allocation as the stepped wedgedesign enabled identification of random allocation at the
beginning and end of the study period. Wounds were
measured from digital photos using Adobe Photoshop
CS5 [17]. The Quick Selection Tool and Histogram were
used to estimate the size of each wound in pixels. The
length (in pixels) of the paper ruler visible in each photo
was then measured, allowing each estimated wound size
to be converted to cm2.
Secondary outcomes were: time to complete healing
(days), percentage of wounds healed, PU incidence, PU
prevalence, wound pain (Visual Analogue Scale-Pain),
hospitalization, emergency department visits, utility
(EQ5D), and cost effectiveness. Research assistants ad-
ministered surveys every 2 weeks throughout the study
period (EQ5D, VAS-Pain). The EQ5D and VAS-Pain
were administered to mentally competent residents. The
EQ5D was also measured by proxy (the clinician most
familiar with each enrolled resident). PUs were followed
until healed, or until the end of the study period, which-
ever came first. A research assistant, trained in chart ab-
straction, abstracted data from resident’s facility charts
at the end of the study period to capture hospital admis-
sions, emergency department visits, and cost.
Sample size estimation
We simulated data under a stepped wedge design over a
17‐month study duration using normalized wound sizes
in a hierarchical linear model with between‐ulcer vari-
ation in healing rates (a mean of –0.0865 (per week) and
a standard deviation of 0.038). The mean was chosen to
reflect the 12‐week mean healing time of Stage II pres-
sure ulcers [18], while the standard deviation reflects a
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possibility of observing ulcers that are increasing in size
up to a maximum of 200% over the study duration. We
used a between‐facility standard deviation of 0.02 [19] in
the distribution of the treatment effects, in a stepped
wedge design with between five and 10 facilities, 170 pa-
tients per facility, and a 20% drop‐out rate applied at
baseline, as well as measurement error of normalized
wound surface areas (0.1 standard deviation units). The
percentage of ulcers that were estimated to not respond
to the intervention was 20%, the prevalence of Stage II‐
IV ulcers was 4%, and the annual incidence of Stage II‐
IV pressure ulcers was 2.5% [20]. After discussion with
wound care clinical experts that included a plastic sur-
geon, a nurse practitioner, enterostomal therapists, a
chiropodist, and advance practice nurses, we estimated
the minimal clinically important difference to be a 40%
improvement in the normal rate of healing (8.65% per
week), which corresponded to an absolute healing rate
of 12.11% per week. Using the R statistical software (ver-
sion 2.9.1), we simulated 1000 datasets under the
stepped wedge design for each combination of the num-
ber of facilities and the treatment effect. The power was
estimated as the proportion of significant treatment ef-
fects, across the 1000 simulated datasets. 80% power was
considered adequate. Because the effect of the treatment
is estimated by comparing the pre and post-intervention
healing rates within each facility, one issue important to
the design of standard cluster randomized trials does
not apply here: the relative sizes of the between-facility
and within-facility variation in healing rates (i.e., theTable 2 PU prevalence
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reported to study staff at study start
(i.e. Oct 2010 for facilities 1-10; April


















Mean(SD) 8.1 (1.9) 3.7 (1.7)
*7residents excluded from bedside audit as requested by Director of Care.
**Director of Care stopped referring residents with PUs to the study APN during phICC) were unimportant. The between-facility variation
in healing rates is captured by the facility-specific ran-
dom effect for rate and only the absolute size of the
within-facility variance is important. Sets of simulations
with different values for the between-facility variance all
gave essentially the same simulated power. Based on the
above assumptions a study with 10 facilities had 80%
power to detect a 40% increase in the healing rate, under
a 5% significance level.
Statistical methods
Demographic and clinical characteristics of residents par-
ticipating in the study, as well as the characteristics of the
PUs observed during the study, were described with means
and standard deviations for continuous variables and fre-
quencies and percentages for categorical variables.
Healing rate was analyzed with the use of linear mixed
effects models [21], using log-transformed PU area as
outcome and intervention, time and their interaction,
along with a number of covariates (wound stage, Charlson
Comorbidity Index, PU recurrence, bed bound, and urin-
ary or fecal incontinence) as predictors. The covariates
were selected based on previous evidence of effect on
PU healing [18]. Mixed effects models were used to
account for the hierarchical clustering structure of the
data (multiple measurements per PU, PUs per patient,
patients per facility). PU stage specific subgroup ana-
lyses were also performed. After testing for the propor-
tional hazard assumption, time to healing was analyzed
with Cox Proportional Hazard frailty models [22], using
the same covariates as those for the analysis of theU prevalence (%)
ed on PUs reported
study staff 2 wks.
ior to Intervention
start
PU prevalence (%) based
on PU identification by


















3.5 (2.5) 4.7 (2.0) 3.0 (2.4)
ase 2 of the Intervention.
Figure 2 Facility recruitment.
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estimated using Kaplan-Meier unadjusted method [23].
Incidence rates were estimated and compared between
control and intervention periods using a random effects
model accounting for the heterogeneity between facilities
[24]. Prevalence was estimated and compared between the
two periods with the use of logistic mixed effects models.
Rates of hospitalization and emergency department visits
were analyzed with the use of negative binomial regression
models. Linear mixed effects models were also used for
the analysis of wound related pain and EQ5D utilities
(measuring quality of life) outcomes, after adjusting
for age and other confounders (sex, diabetes, BMI).
All analyses were performed using the R statistical
software (version 2.14.0).
Qualitative evaluation
Purposive sampling (maximum variation) was employed
to select facilities in which to conduct ethnographic ob-
servation and in-depth interviews, with variation in the
following characteristics that may influence PU healing
rates: facility ownership (i.e. for profit vs. non-profit),
staff turnover, PU prevalence rates, and length of expos-
ure to the intervention. Facilities were also selected to
ensure variation in facility size and location (i.e. LHIN).
Interviews were audiotaped and transcribed verbatim by
a professional transcriptionist. APNs kept field notes re-
lated to staff perceptions of, and experiences with the
intervention throughout the intervention period at every
facility (n = 12). Qualitative data were not collected dur-
ing the control period to minimize the presence of study
personnel, and minimize the potential for a Hawthorne
effect.
Data collection and analysis followed an iterative process.
A coding scheme was developed and subsequently revised
in order to account for new themes and concepts that arose
from the re-reading of the transcripts. Key concepts and an
analytic framework were developed that interpreted and
accounted for the empirical data. Data were obtained from
multiple sources to ensure rigour and data quality: re-
searcher observation, in-depth and informal interviews,
APN observations, and bedside audit data. Ethnographic
observation was conducted on multiple floors in facilities
and at various times throughout the day and evening to in-
crease understanding of organizational context. The itera-
tive collection and analysis of data ensured that we could
test hypotheses, or explore unexpected findings as they
emerged in the analysis. In addition, the report was sent to
the APNs for feedback and their comments incorporated.
Economic evaluation
A comprehensive paper describing the methods used for
the economic evaluation can be found elsewhere [25].
The primary analysis estimated the change in direct carecosts associated with introducing 'enhanced' multi-
disciplinary wound care teams (EMDTs) compared to
'usual' care (UC) for the treatment of pressure ulcers in
LTC facilities in Ontario. The perspective of each ana-
lysis was that of the Ontario Ministry of Health and
Long-Term Care (MOHLTC). The time horizon was the
time until residents were first in a wound-free state or




Facility and resident recruitment
Ten facilities were randomly selected to participate in the
study from among 15 consenting eligible facilities. Preva-
lence rates were lower than anticipated (Table 2), and so 2
additional eligible facilities were randomly selected from
the eligible sites and randomized to start date of the
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tegrity of the study design. Therefore 12 eligible facilities in
total, each with an average of 166 beds (SD = 37.1), were
randomized (Figure 2).
137 residents with a total of 259 PUs were recruited
from these 12 facilities during the 17-month study
period (Figure 3) (Table 3).
Outcomes
Primary outcome Fifty-six of the 259 PUs were excluded
from analysis due to having only one measurement.
Wounds in two additional photos were deemed ‘unmeasur-
able’. Therefore, measurements of 201 PUs from 119 resi-
dents were used in the analyses of the primary outcome.
There was no difference in the rate of healing with and
without the intervention, with the average rate of healing
being 1.0058 times slower in the intervention period (95%
CI = 0.985-1.027,p = 0.60) (Table 4).
When analyzed by stage, a similar pattern was
found, with the exception of stage IV PUs where
there was a clinically unimportant, but statistically
significant decrease in healing rates (rate of healingFigure 3 Resident (wound) recruitment.was 1.05 times slower post-intervention, 95% CI =
1.014-1.088, p = 0.0063).
An analysis that compared ulcers treated entirely be-
fore the intervention, with those treated entirely after
the intervention, and with those ulcers that were identi-
fied before the intervention but which were also treated
in the intervention period showed no differences in out-
come (Table 5).
Secondary outcomes All secondary outcomes showed a
similar pattern, with no benefit and wide confidence
intervals.
Time to healing
From the 91 PUs identified during the control period, 28
(30.8%) healed in the control period, and 3 (3.32%) were
censored at the end of the control period. There were 49
(53.86%) wounds whose care continued to the interven-
tion period of which 24 healed (49.0%) while 25 were
censored (51.0%) at the end of the study. From the 110
PUs newly enrolled during the intervention period 42
(43%) healed during the intervention period while 81





Age 81 (12) 83 (12)
Sex (Female) 43 (64.2%) 65 (69.1%)
Charlson co-morbidities
Alzheimer's/Dementia 38 (56.7%) 62 (66.0%)
Diabetes 22 (32.8%) 36 (38.3%)
Stroke/TIA 20 (29.9%) 29 (30.9%)
Diabetes with end organ damage 10 (14.9%) 22 (23.4%)
Paraplegia/Hemiplegia 11 (16.4%) 15 (16.0%)
Any solid tumour 6 (9.0%) 16 (17.0%)
COPD 10 (14.9%) 7 (7.4%)
Congestive Heart Failure 4 (6.0%) 11 (11.7%)
Peripheral Vascular Disease 5 (7.5%) 6 (6.4%)
Myocardial Infarction 3 (4.5%) 6 (6.4%)
Moderate or severe renal disease 1 (1.5%) 4 (4.3%)
Charlson Co-morbidity Index 3 (2) 3 (2)
Other co-morbidities
Hypertension 37 (55.2%) 55 (58.5%)
Osteoarthritis 36 (53.7%) 42 (44.7%)
Osteoporosis 23 (34.3%) 33 (35.1%%)
Coronary Artery Disease 15 (22.4%) 18 (19.1%)
Parkinson's disease 7 (10.4%%) 9 (9.6%)
Contractures 5 (7.5%) 6 (6.4%%)
Spasticity 4 (6.0%) 5 (5.3%)
PU Risk factors
Incontinence (urine) 66 (98.5%) 91 (96.8%)
Incontinence (stool) 58 (86.6%) 79 (84.0%)
Bedbound 49 (81.7%%) 71 (87.7%)
Mental Status (Not alert/not oriented) 52 (77.6%) 78 (83.0%)
Nutritional supplement 55 (82.1%) 80 (85.1%)
Tube Feed 5 (7.5%) 7 (7.4%)
Body Mass Index 25 (8) 24 (6)
*42 participants crossed study phases, extending from control to intervention
i.e. double counted.
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the results of a proportional hazards model of wound
healing, using pre-specified covariates as described in
the Statistical Methods section. Our survival model
shows the same result as the primary analysis, as does
our pre-planned subgroup analyses by wound stage
(Table 7): there is no statistically significant benefit asso-
ciated with the intervention. Facility-level effects were
also explored and differences between facilities were
found (Table 8).Percentage of Wounds Healed
The percentage of wounds healed was evaluated as the
probability of healing at 6 months (n = 201) using non
parametric Kaplan-Meier estimators [22], allocating
healing events (numerator) and exposure time (denom-
inator) to the appropriate study period. The estimation
was done separately for the control and intervention pe-
riods, without adjustment for PU stage. The probability
of healing for the control period was estimated to be
35.0% (22.4, 45.6), and for the intervention period to be
53.4% (41.4, 62.9). This difference is not statistically sig-
nificant as the two confidence intervals overlap.
Incidence rate
The model estimated the incidence rate of the interven-
tion to be 1.12 (0.74, 1.68) times larger than the incident
rate of the control (p = 0.59). Therefore, the model did
not provide evidence of a significant difference of the in-
cidence rate between the control and the intervention
periods. Additionally, the model did not identify a sig-
nificant heterogeneity among the facilities, I-sq = 10%,
p = 0.38.
Wound pain
Mean VAS wound-specific pain scores were estimated to
be 0.39 units higher during the intervention period, but the
difference was not significant (p = 0.42, 95% CI = -055,
1.34).
PU prevalence
The logistic mixed effects model estimated the mean preva-
lence of residents with PUs to be equal to 2.22% (1.79%,
2.76%) in the control period vs. 2.40% (1.81%, 3.19) in the
intervention period. The difference is not statistically sig-
nificant (p = 0.6).
Hospitalizations
The mean hospitalization rate was estimated to be 1.2
(0.62, 2.36) times larger during the intervention period
than during the control period. The difference was not
statistically significant (p = 0.59).
Emergency department (ED) visits
The mean ED visit rate was estimated to be 1.3 (0.58,
2.90) times larger during the intervention period than
during the control period. The difference was not statis-
tically significant (p = 0.52).
Utility
Mean utilities were estimated to be 0.03 (-0.029, 0.088)
units lower during the intervention period than during
the control period. The difference was not statistically
significant (p = 0.32).
Table 4 Primary analysis – healing rate
Description of model Pre-intervention slope
(β) NB: negative values
indicate healing
Effect of intervention
Change in slope (Δ0)
NB: values < 0 indicate benefit
Relative effect on healing
NB: values < 1 indicate benefit
p-value
Estimate 95% CI
Random effect for intercept and slope,
common treatment effect,wound stage, CCI,
recurrence, bedbound, any incontinence
-0.116 0.0055 1.006 0.985-1.027 0.605
Random effect for intercept and slope,
common treatment effect*
-0.114 0.0062 1.006 0.985-1.027 0.539
Random effect for intercept slope, and
treatment effect*
-0.122 0.0171 1.020 0.993-1.042 0.161
Random effect for intercept and slope,
common treatment effect, control for stage
at diagnosis
-0.115 0.0053 1.006 0.985-1.026 0.615
Models run by stage*
Stage II: Random effect
for intercept and slope,
common treatment
effect
-0.116 -0.040 0.968 0.882-1.062 0.079
Stage III: Random effect
for intercept and slope,
common treatment effect
-0.126 0.005 1.005 0.958-1.055 0.828
Stage IV: Random effect
for intercept and slope,
common treatment effect
-0.125 0.050 1.050 1.014-1.088 0.006
Unstageable: Random
effect for intercept and
slope, common treatment
effect
-0.158 0.013 1.013 0.972-1.056 0.534
*indicates unadjusted analysis.
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Thirty seven of the 137 residents (27%) met criteria for re-
ferral to the expert team. Twenty five of the 37 residents
(68%) were actually referred to the team, with a total of 28
consults. Twelve of the 37 residents (32%) were not referred
to the EMDT despite meeting referral criteria; two of the
12 not referred to the EMDT were seen by specialists situ-
ated in hospitals adjacent to the LTC facilities, one APN felt
facility lack of adherence to treatment recommendations
made referrals for 4 residents futile, while no reason was
cited for non-referral of 6 residents.The Nurse Practitioner
attended all consultations, the chiropodist attended 16
(57%), the OT attended 13 (46%), the plastic surgeon
attended 3 (11%), and an orthopedic surgeon attended 1. A




NB: negative values in
(a) Pre-intervention -0.156 (0.087) 0.050 (0.094)
(b) Post-intervention -0.106 (0.030)
(c) Pre-and post-intervention N/A -0.070 (0.047)of the 28 consults (25%). Most consults occurred by email
followed by a telephone call (n = 25, 89%). 2 consults were
face to face at the hospital based wound clinic, and 1 con-
sult occurred remotely via video-link.
Data abstracted from resident’s charts revealed one
case of referral to a hospital based plastic surgeon and
chiropodist during the control period. This LTC facility
was located directly beside a large teaching hospital.
Qualitative
The qualitative study results are presented in full else-
where [25]. In summary, data collection and analyses
from in-depth interviews and observation conducted in
5 of the 12 facilities, in addition to interviews conducted
with members of the expert wound team in the hospital,rates (Standard error)
dicate benefit
Relative effect on healing (95% CI) p-value
1.051 (0.874-1.263) 0.5916
0.932 (0.850-1.022) 0.1363
Table 6 Hazard ratios, time to healing
Variable Hazard ratio (95% CI) p-value
Intervention 1.48 (0.79,2.78) 0.22
Log(initial PU area) 0.65 (0.51,0.83) 0.00045
Para/hemiplegia or CVA 0.76 (0.43,1.36) 0.36
CCI = 3-5 vs. CCI = 0-2 1.54 (0.90,2.64) 0.12
CCI ≥ 6 vs. CCI = 0-2 0.68 (0.31,1.49) 0.34
Recurrent PU 1.55 (0.41,5.85) 0.52
CCI = Charlson Co-morbidity Index.
CVA = Cerebrovascular accident.















Table 9 Comparison of direct care costs incurred until
healing
Cost category UC EMDTs Difference
Personnel costs
Study nurse N/A $101 $101
MDT N/A $20 $20
ET $357 $18 -$340
Facility nurse $1,094 $1,486 $392
Total personnel costs $1,451 $1,624 $173
Treatments and supplies costs
Antibiotics $84 $38 -$46
Dressings $1,623 $2,284 $661
NPWT $3,142 $0 -$3,142
Total treatments and supplies costs $4,849 $2,322 -$2,527
Hospital costs
Inpatient $4,147 $5,792 $1,645
Ambulatory (ER) $250 $310 $60
Total hospital costs $4,397 $6,102 $1,705
Grand Total $10,697 $10,048 -$649
Grand total (w/o Dressings costs) $9,074 $7,764 -$1,310
Grand total (w/o NPWT costs) $7,555 $10,048 $2,493
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leadership played in ensuring implementation of the inter-
vention. Although the intervention was well received in
most facilities, inadequate allocation of staff time to its im-
plementation, and unavailability of the required wound
care supplies, prohibited effective uptake of the interven-
tion across most facilities.
Economic
The economic study results are presented in full else-
where [25]. In summary, EMDTs were estimated to re-
duce direct care costs by $649 per resident, (Table 9)
although this estimate was subject to substantial uncer-
tainty. This was driven by cancellations of prescribed
Negative Pressure Wound Therapy (NPWT) by the out-
reach APNs, and thus reduced costs, offset by an in-
crease in costs related to increased hospital admissions
in the intervention period.
Discussion
The study was powered to detect a 40% difference in the
primary outcome, rate of healing. Our findings show no
significant improvement in rate of healing, with a nar-
row confidence interval. None of the secondary out-
comes showed significant benefit. In spite of its clinical
equivalence, the economic evaluation provided some evi-
dence of a cost reduction. This was largely attributed to
the discontinuation of NPWT on all residents in the
intervention period. This decision by outreach APNs
was appropriate as there is no evidence of effectiveness
of this therapy for the treatment of pressure ulcers [26].
This resulted in a net savings of $649/resident. Thus al-
though not superior in clinical outcomes, EMDTs may
nonetheless be cost effective. Arguably, though, thereTable 7 Time to healing by wound stage
Wound stage Hazard ratio (95% CI) p-value
II 1.02 (0.40,2.63) 0.96
III 2.16 (0.87,5.34) 0.096
IV 1.58 (0.20,12.67) 0.66
Unstageable 1.00 (0.24,4.17) 1.0
Grand total (w/o Hospital costs) $6,300 $3,946 -$2,354
Grand total (w/o Dressings, NPWT costs) $5,932 $7,764 $1,832
Grand total (w/o Dressings, Hospital
costs)
$4,677 $1,662 -$3,015
Grand total (w/o NPWT, Hospital costs) $3,158 $3,946 $788
Grand total (w/o Dressings, NPWT,
Hospital costs)
$1,535 $1,662 $127
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single, extremely expensive and unproven treatment.
Although the hospital based expert wound team
played an important role for a small number of partici-
pants, and virtual communication between facilities,
APNs, and the expert wound team was feasible, this
study illustrates the relatively minor role played by this
team for the treatment of PUs for residents in this study.
Our qualitative work suggests that, even in these po-
tentially atypical consenting facilities, the intervention
was not well embedded due to frequent staff turnover
and insufficient managerial attention, suggesting that
widespread implementation of this intervention under
present conditions of LTC management would be chal-
lenging. Given these difficulties, and the high levels of
satisfaction and engagement by LTC staff with the out-
reach APN when present in the LTC facility, we suggest
that the intervention be more likely to succeed given a
longer period of implementation, and that the whole of
this be conducted using face to face APN support, rather
than remote, approaches. This would of course, substan-
tially raise the cost, perhaps eliminating the current
benefit.
Although we adjusted for known predictors of
wound healing, and there is no evidence explicitly
linking advanced age and poor health status to
wound healing, residual differences in these factors
may have impaired wound healing in the interven-
tion period, so our estimates of effectiveness may be
somewhat pessimistic.
This study was limited to one particular expert wound
care team located within a large teaching hospital
and may not be representative of all expert multi-
disciplinary wound care teams. 21 of 63 (33.3%) fa-
cility administrators agreed to participate. Therefore
the facilities that participated in this study may not be a
representative sample, but both of these potential
biases would be expected to increase the effectiveness
of the intervention.
We observed a large proportion of censored obser-
vations (n = 107, 53.2%), which reduces the effective
sample size of the analysis, potentially introducing
bias for the estimate of the time to healing, resulting
in potentially inaccurate approximations of the vari-
ances used in the analysis. Additionally, any occur-
rence of uneven censoring due to uneven lengths of
observation time between the two periods may po-
tentially introduce bias in the estimation of the dif-
ference of the healing time between the two periods.
However, the narrow confidence interval around
clinically insignificant results suggests that this issue
may not be important.
We adhered to the recently published methodological
recommendations for comparative effectiveness researchon chronic wounds [27], including the conduct of an eco-
nomic evaluation to inform health care policy decision
making. Studies of various wound treatments and prod-
ucts abound, typically sponsored by product companies,
however studies addressing health service delivery models
for wound care are limited.
Our study results are aligned with other studies that
show no impact of specialist teams- in this case pharma-
cist/wound care nurse- on healing PUs on residents in
LTC [28], and others that highlight the importance of ef-
fective leadership in LTC [29,30], consequences of high
rates of staff turnover in these settings [31-33], and chal-
lenges in meeting residents’ needs within the current re-
source constraints. The feasibility of conducting wound
consults remotely is also supported by the literature
[34,35].Conclusions
PUs tend to be largely overlooked as LTC facility staff
are busy reacting to more pressing issues (eg. disruptive
behaviors, falls), and due to incentives in the reimburse-
ment policies in place at the time this study was con-
ducted, facilities could get extra costs related to wound
care covered by the MOHLTC (e.g. costs for NPWT)
once residents had advanced PU’s, reducing the incen-
tive to address wounds proactively.
Incentives to prevent wounds across health care sec-
tors might be needed as a precursor to interventions
such as EMDTs. Our study findings suggest that policy
makers should shift their focus away from specialty
multi-disciplinary wound care teams external to facil-
ities and direct their attention towards strengthening
evidence based primary care within LTC. Use of out-
reach APNs to increase the capacity of existing staff in
LTC to prevent wounds may be a more sustainable and
effective model, providing effective management teams
are in place and APNs are readily available to facilities
for an extended period of time.
Future research is needed to increase our understanding
of multi-disciplinary team functioning in LTC especially in
relation to improved in-house capacity to prevent wounds.
Based on this new knowledge, interventions could then be
developed and evaluated to improve the organization and
delivery of primary care in these settings which would in
turn support appropriate and timely referral to external
specialty wound care teams.
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